• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Midkine enhances fibrinolytic activity of bovine endothelial cells.

作者信息

Kojima S, Muramatsu H, Amanuma H, Muramatsu T

机构信息

Laboratory of Gene Technology and Safety, Tsukuba Life Science Center, Institute of Physical and Chemical Research (RIKEN), Ibaraki, Japan.

出版信息

J Biol Chem. 1995 Apr 21;270(16):9590-6. doi: 10.1074/jbc.270.16.9590.

DOI:10.1074/jbc.270.16.9590
PMID:7721890
Abstract

A hitherto unknown function of midkine (MK) was found in the regulation of fibrinolytic activity of vascular endothelial cells. Recombinant murine MK enhanced plasminogen activator (PA)/plasmin levels in bovine aortic endothelial cells (BAECs) in a dose- and time-dependent manner. After incubation with 10 ng/ml MK for 18 h, PA and plasmin levels increased 6- and 4-fold, respectively. This effect was attributed to a moderate upregulation of urokinase-type PA expression as well as to a significant down-regulation of PA inhibitor-1 (PAI-1) expression. BAECs constitutively synthesized and secreted MK and its production was enhanced 2-fold with 1 microM retinoic acid or 10 microM retinol. It was found that MK served as a substrate for tissue transglutaminase. In the culture medium, MK existed as a transglutaminase-mediated complex of 36 kDa. Addition of anti-MK antibody to BAEC cultures resulted in a decrease of basal PA activity and an increase of basal PAI-1 levels and attenuated the ability of retinol to enhance PA activity 50% and potentiated the ability to increase PAI-1 levels 4-fold. Furthermore, MK and basic fibroblast growth factor (bFGF) acted more than additively in enhancing PA levels. We conclude that in BAECs MK is a novel autocrine factor sustaining the fibrinolytic property. MK functions as a mediator of retinoid and cooperates with bFGF to enhance fibrinolytic activity of BAECs.

摘要

相似文献

1
Midkine enhances fibrinolytic activity of bovine endothelial cells.
J Biol Chem. 1995 Apr 21;270(16):9590-6. doi: 10.1074/jbc.270.16.9590.
2
Enhancement of fibrinolytic activity of bovine aortic endothelial cells by ginsenoside Rb2.人参皂苷Rb2对牛主动脉内皮细胞纤溶活性的增强作用。
Acta Pharmacol Sin. 2003 Feb;24(2):102-8.
3
Basic fibroblast growth factor-induced activation of latent transforming growth factor beta in endothelial cells: regulation of plasminogen activator activity.碱性成纤维细胞生长因子诱导内皮细胞中潜伏转化生长因子β的激活:纤溶酶原激活物活性的调节
J Cell Biol. 1992 Aug;118(4):901-9. doi: 10.1083/jcb.118.4.901.
4
Requirement for transglutaminase in the activation of latent transforming growth factor-beta in bovine endothelial cells.牛内皮细胞中潜伏转化生长因子-β激活对转谷氨酰胺酶的需求。
J Cell Biol. 1993 Apr;121(2):439-48. doi: 10.1083/jcb.121.2.439.
5
Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis.血管生成抑制性类固醇的作用机制:通过刺激纤溶酶原激活物抑制剂的合成来抑制纤溶酶原激活物活性。
J Cell Physiol. 1993 Jun;155(3):568-78. doi: 10.1002/jcp.1041550315.
6
Changes in the fibrinolytic components of cultured human umbilical vein endothelial cells induced by endotoxin, tumor necrosis factor-alpha and interleukin-1alpha.内毒素、肿瘤坏死因子-α和白细胞介素-1α诱导的人脐静脉内皮细胞纤溶成分的变化
Haematologica. 1999 Apr;84(4):306-11.
7
Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation.组织型纤溶酶原激活物、1型纤溶酶原激活物抑制剂及其在弥散性血管内凝血患者血浆中的复合物
Thromb Res. 1992 Oct 1;68(1):57-65. doi: 10.1016/0049-3848(92)90127-v.
8
Regulation of plasminogen activator inhibitor activity by plasmin in endothelial cells.纤溶酶对内皮细胞中纤溶酶原激活物抑制剂活性的调节作用。
Thromb Res. 1996 Jan 1;81(1):75-84. doi: 10.1016/0049-3848(95)00215-4.
9
Clusters of basic amino acids in midkine: roles in neurite-promoting activity and plasminogen activator-enhancing activity.
J Biochem. 1998 Jun;123(6):1127-36. doi: 10.1093/oxfordjournals.jbchem.a022052.
10
Synthetic peptides derived from midkine enhance plasminogen activator activity in bovine aortic endothelial cells.
Biochem Biophys Res Commun. 1995 Jan 17;206(2):468-73. doi: 10.1006/bbrc.1995.1066.

引用本文的文献

1
Midkine-A novel player in cardiovascular diseases.中期因子——心血管疾病中的新角色。
Front Cardiovasc Med. 2022 Sep 20;9:1003104. doi: 10.3389/fcvm.2022.1003104. eCollection 2022.
2
Elevated serum midkine levels in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infected patients.严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)感染患者血清中期因子水平升高。
Int Immunopharmacol. 2022 Sep;110:108939. doi: 10.1016/j.intimp.2022.108939. Epub 2022 Jun 9.
3
Involvement of midkine in the development of pulmonary fibrosis.中期因子在肺纤维化发展过程中的作用。
Physiol Rep. 2017 Aug;5(16). doi: 10.14814/phy2.13383.
4
Antiageing Mechanisms of a Standardized Supercritical CO 2 Preparation of Black Jack (Bidens pilosa L.) in Human Fibroblasts and Skin Fragments.标准超临界二氧化碳萃取制备的鬼针草(Bidens pilosa L.)在人成纤维细胞和皮肤碎片中的抗衰老机制
Evid Based Complement Alternat Med. 2015;2015:280529. doi: 10.1155/2015/280529. Epub 2015 Mar 26.
5
Midkine: a novel prognostic biomarker for cancer.中期因子:癌症的一种新型预后生物标志物。
Cancers (Basel). 2010 Apr 20;2(2):624-41. doi: 10.3390/cancers2020624.
6
Loss of heparin-binding protein prevents necrotizing glomerulonephritis: first clues hint at plasminogen activator inhibitor-1.肝素结合蛋白缺失可预防坏死性肾小球肾炎:初步线索提示纤溶酶原激活物抑制剂-1。
Int Urol Nephrol. 2013 Oct;45(5):1483-7. doi: 10.1007/s11255-013-0415-1. Epub 2013 Mar 30.
7
Midkine in inflammation.炎症中的中期因子
ScientificWorldJournal. 2011;11:2491-505. doi: 10.1100/2011/517152. Epub 2011 Dec 27.
8
Genome scan of clot lysis time and its association with thrombosis in a protein C-deficient kindred.基因扫描血块溶解时间及其与蛋白 C 缺乏家族血栓形成的关系。
J Thromb Haemost. 2011 Jul;9(7):1383-90. doi: 10.1111/j.1538-7836.2011.04343.x.
9
Midkine: a promising molecule for drug development to treat diseases of the central nervous system.中期因子:一种有前途的药物开发分子,可用于治疗中枢神经系统疾病。
Curr Pharm Des. 2011;17(5):410-23. doi: 10.2174/138161211795164167.
10
Premature ligand-receptor interaction during biosynthesis limits the production of growth factor midkine and its receptor LDL receptor-related protein 1.在生物合成过程中,过早的配体-受体相互作用限制了生长因子中期因子及其受体 LDL 受体相关蛋白 1 的产生。
J Biol Chem. 2011 Mar 11;286(10):8405-8413. doi: 10.1074/jbc.M110.176479. Epub 2011 Jan 5.